Relating to: a sales and use tax exemption for the sale of over-the-counter drugs. (FE)

SB 1032 would create a sales and use tax exemption for over-the-counter drugs. The bill defines qualifying drugs as those with specific labeling, including a drug facts panel or a list of active ingredients. This exemption would remove sales tax from the purchase of these medications, directly affecting consumers buying common drugs like pain relievers or cold medicine and retailers selling them. The policy change applies only to drugs meeting the defined labeling requirements, not to prescription medications or other products.